fda/nme-approvals·Available

FDA New Molecular Entity Approvals

This is a record of every genuinely new drug the FDA has approved since 1985. You'll find the drug name, what disease it treats, who made it, and when it got approved. The important part: it marks which drugs got special status. Some got 'priority review' (faster approval), some were for rare diseases (orphan drugs), some got 'breakthrough therapy' status because they looked really promising, and some got approved even faster than normal (accelerated approval). People use this data to answer the big question: do high drug prices actually fund real innovation, or is it just markup? By looking at what kinds of drugs got approved each year and which ones got special designations, you can see if the pipeline is actually producing breakthrough treatments or just minor variations on existing drugs.

Source rows:
1,387
Coverage:
1985-01-01T00:00:00Z – 2025-12-31T00:00:00Z

CSV: all rows from the default table.

Table filters, sorting and pagination are not included.

Ask about this data

Explore data

Views organize this dataset for different questions.

Loading views…

Default table

Dataset overview

This overview is independent of the table. Table selections and filters do not change it.

Questions this data answers

Ask your own question about FDA New Molecular Entity Approvals

Download

CSV: all rows from the default table.

Table filters, sorting and pagination are not included.

Columns

27 columns in this table.

Search datasets

Search for datasets or run quick actions